KRMD | tickerfilter.com

Fundamental analysis

48%

Profitability 56%

Dept financing 9%

Liquidity 66%

Performance 45%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

1.39%

1 Month

5.12%

3 Months

48.33%

6 Months

40.03%

1 Year

64.81%

2 Year

17.11%

Key data

Stock price

$4.01

P/E Ratio

0.00

DAY RANGE

$3.93 - $4.02

EPS

$0.00

52 WEEK RANGE

$2.09 - $4.60

52 WEEK CHANGE

$73.38

MARKET CAP

115.555 M

YIELD

N/A

SHARES OUTSTANDING

45.855 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/06/2024

BETA

1.44

PUBLIC FLOAT

AVERAGE 10 VOLUME

$95,790

AVERAGE 30 VOLUME

$85,409

Company detail

CEO: Linda M. Tharby
Region: US
Website: korumedical.com
Employees: 80
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Repro Med Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company also provides education and training materials to clinicians, patients, and patient advocates.

KRMD - KORU Medical Systems, Inc.